文献速递糖尿病

全球20-79岁成人糖尿病经济负担:一项疾病成本研究

The global economic burden of diabetes in adults aged 20-79 years: a cost-of-illness study.
PubMed 文献 · Lancet Diabetes Endocrinol · 2017-04-26

该研究采用统一框架估算2015年184个国家20-79岁成人糖尿病的全球经济负担。结果显示全球糖尿病成本为1.31万亿美元(95%CI 1.28-1.36),占全球GDP的1.8%(95%CI 1.8-1.9),其中间接成本占34.7%(95%CI 34.7-35.0)。

要点

  • 2015年全球20-79岁成人糖尿病成本为1.31万亿美元(95%CI 1.28-1.36),占全球GDP的1.8%(95%CI 1.8-1.9)。
  • 间接成本占总负担的34.7%(95%CI 34.7-35.0),但各国间接成本占比和构成存在较大差异。
  • 按占GDP比例,中等收入国家平均经济负担高于高收入国家;北美相对GDP受影响最大且绝对成本贡献最大。

核心结论

  • 研究结果表明糖尿病造成了巨大的全球经济负担。
  • 尽管低收入和中等收入国家可用数据有限,但研究结果提示大量糖尿病相关成本不仅是高收入地区的问题,也影响较贫困的世界区域。

研究设计与样本

  • 研究使用184个国家的流行病学和经济数据估算全球糖尿病经济负担,不区分糖尿病类型。
  • 直接成本采用自上而下法,基于WHO一般卫生支出数据和2015年国际糖尿病联盟糖尿病地图集的患病率数据。
  • 间接成本采用人力资本法评估,包括糖尿病相关发病和过早死亡。

主要发现

  • 估算2015年全球糖尿病成本为1.31万亿美元(95%CI 1.28-1.36),占全球GDP的1.8%(95%CI 1.8-1.9)。
  • 间接成本占总负担的34.7%(95%CI 34.7-35.0),各国间接成本占比和构成存在较大差异。
  • 北美相对GDP受影响最大,同时也是全球绝对成本的最大贡献者。
  • 按占GDP比例平均计算,中等收入国家的经济负担大于高收入国家。

局限性

  • 低收入和中等收入国家可用数据有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Differences in methods and data used in past studies have limited comparisons of the cost of illness of diabetes across countries. We estimate the full global economic burden of diabetes in adults aged 20-79 years in 2015, using a unified framework across all countries. Our objective was to highlight patterns of diabetes-associated costs as well as to identify the need for further research in low-income regions. METHODS: Epidemiological and economic data for 184 countries were used to estimate the global economic burden of diabetes, regardless of diabetes type. Direct costs were derived using a top-down approach based on WHO general health expenditure figures and prevalence data from the 2015 International Diabetes Federation Diabetes Atlas. Indirect costs were assessed using a human-capital approach, including diabetes-associated morbidity and premature mortality. FINDINGS: We estimate the global cost of diabetes for 2015 was US$1·31 trillion (95% CI 1·28-1·36) or 1·8% (95% CI 1·8-1·9) of global gross domestic product (GDP). Notably, indirect costs accounted for 34·7% (95% CI 34·7-35·0) of the total burden, although substantial variations existed both in the share and the composition of indirect costs across countries. North America was the most affected region relative to GDP and also the largest contributor to global absolute costs. However, on average, the economic burden as percentage of GDP was larger in middle-income countries than in high-income countries. INTERPRETATION: Our results suggest a substantial global economic burden of diabetes. Although limited data were available for low-income and middle-income countries, our findings suggest that large diabetes-associated costs are not only a problem in high-income settings but also affect poorer world regions. FUNDING: None.

来源:Lancet Diabetes Endocrinol,查看原文。版权归原作者所有。

引用

  1. Bommer C, Heesemann E, Sagalova V, et al. The global economic burden of diabetes in adults aged 20-79 years: a cost-of-illness study. Lancet Diabetes Endocrinol. 2017. PMID: 28456416. doi:10.1016/S2213-8587(17)30097-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。